Eflapegrastim versus Pegfilgrastim for Chemotherapy-Induced Neutropenia in Korean and Asian Patients with Early Breast Cancer: Results from the Two Phase III ADVANCE and RECOVER Studies

PURPOSE: We investigated the consistent efficacy and safety of eflapegrastim, a novel long-acting granulocyte-colony stimulating factor (G-CSF), in Koreans and Asians compared with the pooled population of two global phase 3 trials. MATERIALS AND METHODS: Two phase 3 trials (ADVANCE and RECOVER) eva...

Descripción completa

Detalles Bibliográficos
Autores principales: Moon, Yong Wha, Kim, Seung Ki, Lee, Keun Seok, Lee, Moon Hee, Park, Yeon Hee, Park, Kyong Hwa, Kim, Gun Min, Lim, Seungtaek, Lee, Seung Ah, Choi, Jae Duk, Baek, Eunhye, Han, Hyesun, Baek, Seungjae, Im, Seock-Ah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372586/
https://www.ncbi.nlm.nih.gov/pubmed/36701846
http://dx.doi.org/10.4143/crt.2022.987

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372586/
https://www.ncbi.nlm.nih.gov/pubmed/36701846
http://dx.doi.org/10.4143/crt.2022.987

Ejemplares similares